Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TQT Study of Tizanidine
NCT01839279Phase 2Completed
- Sponsor
- Acorda Therapeutics
- Start
- Apr 2013
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tizanidine in spasticity, sponsored by Acorda Therapeutics. Started Apr 2013; status: completed.
02
Drugs
tizanidine
03
Conditions
spasticity
Beyond the preview
Go deeper on NCT01839279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01839279.